{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,21]],"date-time":"2025-12-21T18:23:35Z","timestamp":1766341415973,"version":"3.48.0"},"reference-count":6,"publisher":"BMJ","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Evid Based Nurs"],"accepted":{"date-parts":[[2025,12,11]]},"DOI":"10.1136\/ebnurs-2025-104479","type":"journal-article","created":{"date-parts":[[2025,12,21]],"date-time":"2025-12-21T18:20:18Z","timestamp":1766341218000},"page":"ebnurs-2025-104479","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["More than a dose taper: context and prediction in antipsychotic withdrawal for intellectual disability"],"prefix":"10.1136","author":[{"given":"Alvaro","family":"Cavieres","sequence":"first","affiliation":[{"name":"Department of Psychiatry, Universidad de Valpara\u00edso, Valpara\u00edso, Chile"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2025,12,21]]},"reference":[{"key":"2025122110200822000_ebnurs-2025-104479v1.1","first-page":"397","article-title":"Psychotropic drug use in adults with intellectual disabilities: a systematic review","volume":"66","author":"Garc\u00eda-Dom\u00ednguez","year":"2022","journal-title":"J Intellect Disabil Res"},{"key":"2025122110200822000_ebnurs-2025-104479v1.2","doi-asserted-by":"crossref","first-page":"1609408","DOI":"10.3389\/fpsyt.2025.1609408","article-title":"Antipsychotic medication for behaviors that challenge in individuals with intellectual disabilities: a clinically informed review","volume":"16","author":"Pascucci","year":"2025","journal-title":"Front Psychiatry"},{"key":"2025122110200822000_ebnurs-2025-104479v1.3","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S2215-0366(16)30191-2","article-title":"Reduction or discontinuation of antipsychotics for challenging behaviour in adults with intellectual disability: a systematic review","volume":"4","author":"Sheehan","year":"2017","journal-title":"Lancet Psychiatry"},{"key":"2025122110200822000_ebnurs-2025-104479v1.4","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1111\/jir.70038","article-title":"Off-Label Antipsychotic Withdrawal in People With Intellectual Disabilities: Development and Internal Validation of a Prediction Model","volume":"69","author":"Weijgertze-Lanser","year":"2025","journal-title":"J Intellect Disabil Res"},{"key":"2025122110200822000_ebnurs-2025-104479v1.5","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph192417095","article-title":"Withdrawing Antipsychotics for Challenging Behaviours in Adults with Intellectual Disabilities: Experiences and Views of Prescribers","volume":"19","author":"de Kuijper","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"2025122110200822000_ebnurs-2025-104479v1.6","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.176.1.42"}],"container-title":["Evidence Based Nursing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ebnurs-2025-104479","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,21]],"date-time":"2025-12-21T18:20:19Z","timestamp":1766341219000},"score":1,"resource":{"primary":{"URL":"https:\/\/ebn.bmj.com\/lookup\/doi\/10.1136\/ebnurs-2025-104479"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,21]]},"references-count":6,"alternative-id":["10.1136\/ebnurs-2025-104479"],"URL":"https:\/\/doi.org\/10.1136\/ebnurs-2025-104479","relation":{},"ISSN":["1367-6539","1468-9618"],"issn-type":[{"value":"1367-6539","type":"print"},{"value":"1468-9618","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,21]]}}}